CHF and Arrhythmias

Medication Errors Resulting in Death Most Common in Elderly

December 13, 2018

Medication errors in acute care that result in death occur most often in patients older than 75 years, with the most common error category being omitted medicine or ingredient.

Botox Injections Explored to Cut Postop A-Fib in Cardiac Surgery

December 07, 2018

Intraoperative botulinum toxin (BTX) injections show promise as a way to reduce the risk for postoperative atrial fibrillation (AF) following cardiac surgery, according to 2 studies recently published.

Meds Taken Do Not Vary With ADL Impairment in Heart Failure

December 07, 2018

For individuals with heart failure, those with impairment in activities of daily living (ADL) take as many medications as those without ADL impairment.

Renin-angiotensin inhibitors may improve outcomes of transcatheter aortic valve replacement patients

December 06, 2018

In this retrospective cohort study of transcatheter aortic valve replacement patients, Renin-Angiotensin System inhibitors administered at hospital discharge reduced mortality and hospital readmission in patients with preserved but not reduced Left Ventricular Ejection Fraction.

Migraine Subtype Linked to Increased Risk of Incident Atrial Fibrillation

December 05, 2018

Migraine with aura is associated with an elevated risk for incident atrial fibrillation, according to a new study.

Marathon Runners Show Markers of Cardiac Strain

December 05, 2018

Running a marathon can increase cardiac strain in amateur runners, according to new research.

Physician's Decision to Discontinue Med Leads to Lawsuit After Patient Suffers Stroke

By December 03, 2018

This month we look at a case where a physician made a judgment call and ended up being judged harshly for it.

Climate Change Ups Heat Deaths, Especially Among Elderly

November 30, 2018

Last year, 157 million at-risk people were exposed to heat waves worldwide; 18 million more than in 2016.

Physical activity in patients with heart failure and cardiovascular outcomes

November 27, 2018

The current analysis of the HF-ACTION trial sought to evaluate the baseline physical activity effect on the responses to exercise training and clinical outcomes.

Vitamin D Levels Linked to Cardiorespiratory Fitness

November 27, 2018

The researchers found that participants in the highest quartile of vitamin D levels had significantly higher cardiorespiratory fitness than participants in the lowest quartile.

Dapagliflozin May Lower Heart Failure Hospitalizations in Patients With Diabetes

November 14, 2018

Dapagliflozin was not associated with either a higher or lower rate of MACE compared with placebo in patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease.

Low-Dose Methotrexate Does Not Reduce Events in Stable Atherosclerosis

By November 13, 2018

Low-dose methotrexate did not result in a reduced number of cardiovascular events among patients with stable atherosclerosis.

Combining NSAIDs With Oral Anticoagulants Increases Bleeding Risk in AF

November 13, 2018

While the use of NSAIDs was low in the ARISTOTLE trial, NSAID users had a higher risk for bleeding than non-users.

Sensitive cardiac injury marker could reduce stress testing for myocardial ischemia

November 12, 2018

Routine surveillance stress testing is often costly and overused. Furthermore, current guidelines recommend against routine stress testing in patients with stable ischemic CAD, unless the purpose of the test is to assess new or progressive symptoms.

Sacubitril-Valsartan Versus Enalapril in Reducing NT-proBNP in HFrEF

November 12, 2018

A sacubitril-valsartan therapy regimen was associated with greater reductions in NT-proBNP concentrations in patients with HFrEF compared with enalapril.

Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization

November 11, 2018

Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.

Rivaroxaban Has Positive Risk-Benefit Profile for Non-Valvular A-Fib

November 11, 2018

Rivaroxaban given at doses of both 20mg and 15mg may have an improved bleeding risk profile compared with vitamin K antagponist.

Recommendations Issued for Management of Bradycardia

November 09, 2018

Shared decision making and patient-centered care are endorsed and emphasized for patients with bradycardia with indications for pacemaker implantation; treatment decisions should be based on best available evidence and the patient's goals of care.

Influenza Infection Increases Mortality Risk in Acute Myocardial Infarction

November 09, 2018

Investigators examined whether influenza is an independent risk factor for the development of acute myocardial infarction.

Use of Both Aspirin and NSAIDs Associated With Incident Heart Failure Risk

November 09, 2018

The use of both NSAID and aspirin was positively associated with incident heart failure in adults with no prior history of CVD.

Inhaled Nitrite Does Not Improve Exercise Capacity in HFpEF

November 07, 2018

Participants were randomly assigned to 4 weeks of inorganic nitrite or placebo administered via a micronebulizer device followed by a 2-week washout period with no study drug for each 6-week phase of the crossover study.

Opioid Use Appears to Up Risk for Atrial Fibrillation

November 05, 2018

The researchers found that 29.2% of those with AF and 15.4% of those without AF were prescribed opioids.

Some Weather Conditions Linked to Myocardial Infarction Risk

November 01, 2018

The researchers found that incidence of MI increased with lower air temperature, lower atmospheric air pressure, higher wind velocity, and shorter sunshine duration.

Fluoroquinolones Tied to Increased Risk for Arrhythmia, CV Mortality

By October 30, 2018

To investigate the risk of cardiovascular adverse effects associated with this antibiotic class, researchers conducted a systematic review, meta-analysis, and network meta-analysis using studies identified through a search of MEDLINE, EMBASE, and the Cochrane Library.

Cardiac Stem Cell Trial Halted Due to Concerns About Fake Data

October 30, 2018

The clinical trial is based on research from a number of laboratories, including that of Harvard-affiliated Brigham and Women's Hospital researcher Piero Anversa, MD.

Presence of antiphospholipid antibodies important risk factor for myocardial infarction

October 26, 2018

A positive association was found between the antiphospholipid antibody immunoglobulin G and first-time myocardial infarctions in study patients.

Intensive blood pressure lowering favored to not induce kidney disease

October 26, 2018

Patients managed with intensive blood pressure reduction were found to have significantly greater decreases in kidney damage biomarkers compared to standard blood pressure management.

A-Fib, CV Event Risks Examined in PsA Receiving Ustekinumab vs TNF Inhibitors

October 22, 2018

The primary and secondary outcomes included incident AF or a composite CV event that included myocardial infarction, stroke, and coronary revascularization.

Harvard: Heart Researcher's Papers Contain Fraudulent Data

October 17, 2018

Anversa has published more than 100 scientific papers, has collaborated with leaders in the field of heart research, and was honored as a distinguished scientist by the American Heart Association, the Post reported.

CHF in Pregnancy Up for Cancer Survivors With Cardiac Toxicity

October 16, 2018

Compared to women without CHF, those with CHF during pregnancy were more likely to have had a history of cardiotoxicity before pregnancy (100 vs 12%).